Tirzepatide Lyophilized High Purity 99% Peptide Hmoov Tr 10

Tirzepatide yog cov khoom noj qab zib-instulinotropic polypected tau pom zoo glycemic tswj nyob rau hauv cov neeg laus uas muaj hom 2 ntshav qab zib thiab kev tshawb nrhiav rau siv Kev tswj lub cev yuag, cov xwm txheej tsis zoo ntawm lub plawv, suav nrog lub plawv tsis ua haujlwm nrog kev lom zem tsis muaj kev lom zem tsis-cawv tsis muaj cawv. Lub theem 3 nce mus rau 1-5 chaw kuaj mob tau tsim los txheeb xyuas qhov ua tau zoo thiab kev nyab xeeb ib zaug txhaj lossis kev kho mob ntawm cov neeg muaj ntshav qab zib hom 2. Kev siv Tirzepatide hauv cov kev tshawb fawb soj ntsuam tau cuam tshuam nrog cov cim kev txo ntawm glycated hemlobin (-1.59% rau -2.9 kg), nrog rau kev txo qis hauv qhov tsis muaj tseeb cuam ​​tshuam nrog kev sib tw ntawm daim tawv plawv plawv kev phom sij xws li ntshav siab, visceral adiposity thiab circulating triglycerides. Tirzepatide tau zoo zam, nrog txoj kev pheej hmoo tsawg ntawm hypoglycaemia thaum siv tsis muaj insulin lossis insulin zais cia ntse rau GLP-1 tus kws tshaj lij kev nyab xeeb hauv GLP-1 tus neeg ua haujlwm hauv chav kawm. Raws li, cov ntaub ntawv pov thawj los ntawm cov chaw kuaj mob no qhia tias Tirzepatide muaj lub sijhawm tshiab rau kev ua kom qis dua ntawm glycated hemoglobin thiab lub cev hnyav rau cov neeg laus muaj hom 2 ntshav qab zib.